Glassman Wealth Services Novavax Inc Transaction History

Glassman Wealth Services

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$8.86 - $25.04 $44 - $125	-5 Reduced 27.78%	13 $0
Q3 2022 Nov 09, 2022	SELL	$18.2 - $76.12 $764 - $3,197	-42 Reduced 70.0%	18 $0
Q2 2022 Aug 04, 2022	BUY	$36.28 - $75.29 $1,668 - $3,463	46 Added 328.57%	60 $3,000
Q1 2022 Aug 23, 2022	BUY	$69.73 - $142.9 $69 - $142	1 Added 7.69%	14 $1,000
Q1 2022 Apr 14, 2022	BUY	$69.73 - $142.9 $488 - $1,000	7 Added 116.67%	13 $1,000
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $1,076 - $1,743	-8 Reduced 57.14%	6 $1,000
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $711 - $1,082	4 Added 40.0%	14 $3,000
Q1 2021 May 05, 2021	SELL	$112.98 - $319.93 $15,817 - $44,790	-140 Reduced 93.33%	10 $2,000
Q3 2020 Nov 09, 2020	SELL	$79.44 - $178.51 $4,448 - $9,996	-56 Reduced 27.18%	150 $16,000
Q2 2020 Aug 06, 2020	BUY	$13.86 - $83.61 $2,855 - $17,223	206 New	206 $17,000
Q4 2019 Feb 07, 2020	SELL	$3.69 - $5.22 $184 - $261	-50 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$4.93 - $12.2 $246 - $610	50 New	50 $0

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.